MCK logo

McKesson (MCK)

Profile

Full Name

McKesson Corporation

Ticker Symbol

MCK

Exchange

NYSE

Sector

Healthcare

Industry

Medical Distribution

Country

United States

IPO

November 10, 1994

Indexes

S&P 500

Website

http://www.mckesson.com

Employees

45000

Key Details

Price

$693.98(+0.67%)

Market cap

Last Dividend

$0.71

TTM Dividend yield

0.40%

Annual revenue

$308.95B(+11.65% YoY)

Annual EPS

$22.39(-10.55% YoY)

PE ratio

31.78

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$693.98
MCK price is $693.98

30-Day Relative Volume

0.90
MCK 30-day relative volume is 0.90

Price Performance

Price Most recent change

+0.67%
MCK price was up +0.67% on Apr 14, 2025

Price YTD change

+21.77%
MCK price is up +21.77% since January 1st

Price 1-year change

+32.69%
MCK price is up +32.69% year-on-year

Price 3-year change

+114.69%
MCK price is up +114.69% over the past 3 years

Price Range

Price All-time high

$728.32
MCK price is currently -4.71% below its historical high of $728.32

Price 3-year low

$298.69
MCK price is currently +132.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$86.97B
MCK market capitalization is $86.97 billion

Market cap 3-year change

+85.56%
MCK market capitalization is up +85.56% over the past 3 years

Market cap All-time high

$89.85B
MCK market capitalization is currently -3.20% below its historical high of $89.85 billion

Market cap sector rank

98.03%
MCK market capitalization is higher than 98.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.9%
MCK shares outstanding is down -3.9% year-on-year

Shares Outstanding 3-Year Change

-13.57%
MCK shares outstanding is down -13.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.14
MCK beta is 0.14

200-day SMA

$582.84
MCK price is currently +19.07% above its 200-day simple moving average

50-day SMA

$642.21
MCK price is currently +8.06% above its 50-day simple moving average

RSI

61.29
MCK 14-day relative strength index is 61.29

Volume

0.90
MCK 30-day relative volume is 0.90

ATR

$23.59
MCK average true range is $23.59

10-day Historical Volatility

42.63%
MCK 10-day historical volatility is 42.63%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.71
MCK last dividend was $0.71 per share, with an ex-dividend date of March 3, 2025

Next Dividend

-
MCK next dividend has not yet been announced

Dividend per share

Dividend per share

$2.40
MCK annual dividend per share is $2.40

Dividend per share Sector Rank

75.58%
MCK annual dividend per share is higher than 75.58% of companies in Healthcare sector

Dividend per share 1-Year Change

+14.83%
MCK annual dividend per share is up +14.83% year-on-year

Dividend per share 3-Year Change

+43.71%
MCK annual dividend per share is up +43.71% over the past 3 years

Dividend yield

Dividend yield

0.35%
MCK annual dividend yield is 0.35%

Dividend yield Sector Rank

9.41%
MCK annual dividend yield is higher than 9.41% of companies in Healthcare sector

Other

Payout ratio

10.46%
MCK annual payout ratio is 10.46%

Dividends paid

$314.00M
MCK annual dividends paid is $314.00 million

Free cash flow

$3.63B
MCK annual free cash flow is $3.63 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$308.95B
MCK annual revenue is $308.95 billion

Revenue Analysts estimate

$362.26B
MCK annual revenue is currently -14.72% lower than the consensus analysts' forecast

Revenue 1-year change

+11.65%
MCK annual revenue is up +11.65% year-on-year

Revenue Sector rank

99.78%
MCK annual revenue is higher than 99.78% of companies in Healthcare sector

EPS

EPS

$22.39
MCK annual earnings per share is $22.39

EPS Analysts estimate

$32.75
MCK annual earnings per share is currently -31.64% lower than the consensus analysts' forecast

EPS 1-year change

-10.55%
MCK annual earnings per share is down -10.55% year-on-year

EPS Sector rank

99.42%
MCK annual earnings per share is higher than 99.42% of companies in Healthcare sector

Profit

Gross profit

$12.83B
MCK annual gross profit is $12.83 billion

Gross margin

4.15%
MCK annual gross profit margin is 4.15%

Operating profit

$4.17B
MCK annual operating income is $4.17 billion

Operating margin

1.35%
MCK annual operating profit margin is 1.35%

Net income

$3.00B
MCK annual net profit is $3.00 billion

Net margin

0.97%
MCK annual net profit margin is 0.97%

Expenses

Total expenses

$304.78B
MCK annual total expenses is $304.78 billion

Operating expenses

$8.66B
MCK annual total operating expenses is $8.66 billion

Cost of goods sold

$296.12B
MCK annual cost of goods sold is $296.12 billion

Selling, general & administrative expenses

$8.66B
MCK annual SGA is $8.66 billion

Depreciation and amortization

$635.00M
MCK annual depreciation & amortization is $635.00 million

Interest expense

$252.00M
MCK annual interest expense is $252.00 million

Income tax

$629.00M
MCK annual income tax is $629.00 million

EBIT & EBITDA

EBIT

$4.04B
MCK annual earnings before interest & taxes is $4.04 billion

EBITDA

$4.68B
MCK annual EBITDA is $4.68 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$67.44B
MCK annual total assets is $67.44 billion

Non current assets

$19.47B
MCK annual long term assets is $19.47 billion

Current assets

$47.97B
MCK annual total current assets is $47.97 billion

Cash and cash equivalents

$4.58B
MCK annual cash & cash equivalents is $4.58 billion

Accounts receivable

$19.44B
MCK annual accounts receivable is $19.44 billion

Inventory

$21.14B
MCK annual inventory is $21.14 billion

Liabilities

Total liabilities

$69.04B
MCK annual total liabilities is $69.04 billion

Long term liabilities

$16.68B
MCK annual total long term liabilities is $16.68 billion

Current liabilities

$52.36B
MCK annual total current liabilities is $52.36 billion

Accounts payable

$47.10B
MCK annual accounts payable is $47.10 billion

Debt

Total debt

$7.39B
MCK annual total debt is $7.39 billion

Total debt 1-year change

+1.3%
MCK annual total debt is up +1.3% year-on-year

Long term debt

$7.04B
MCK annual long term debt is $7.04 billion

Short term debt

$345.00M
MCK annual short term debt is $345.00 million

Equity & Capital

Shareholders equity

-$1.97B
MCK annual stockholders equity is -$1.97 billion

Book value

-$1.97B
MCK annual book value is -$1.97 billion

Retained earnings

$14.98B
MCK annual retained earnings is $14.98 billion

Working capital

-$4.39B
MCK annual working capital is -$4.39 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.31B
MCK annual cash flow from operations is $4.31 billion

Cash from operations 1-year change

-16.38%
MCK annual cash flow from operations is down -16.38% year-on-year

Cash from investing

-$1.07B
MCK annual cash flow from investing activities is -$1.07 billion

Cash from investing 1-year change

-97.79%
MCK annual cash flow from investing activities is down -97.79% year-on-year

Cash from financing

-$3.34B
MCK annual cash flow from financing activities is -$3.34 billion

Cash from financing 1-year change

+23.49%
MCK annual cash flow from financing activities is up +23.49% year-on-year

CAPEX

CAPEX

$687.00M
MCK annual capital expenditures is $687.00 million

CAPEX 1-year change

+23.12%
MCK annual capital expenditures is up +23.12% year-on-year

Free Cash Flow

Free cash flow

$3.63B
MCK annual free cash flow is $3.63 billion

Free cash flow 1-year change

-21.17%
MCK annual free cash flow is down -21.17% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

4.15%
MCK annual gross profit margin is 4.15%

Operating margin

1.35%
MCK annual operating profit margin is 1.35%

Net margin

0.97%
MCK annual net profit margin is 0.97%

ROA & ROE

ROA

4.63%
MCK annual return on assets is 4.63%

ROE

-152.31%
MCK annual return on equity is -152.31%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

31.78
MCK price to earnings ratio is 31.78

PE ratio Sector rank

63.24%
MCK price to earnings ratio is higher than 63.24% of companies in Healthcare sector

PB Ratio

PB ratio

-28.20
MCK price to book ratio is -28.20

PB ratio Sector rank

1.07%
MCK price to book ratio is higher than 1.07% of companies in Healthcare sector

PS Ratio

PS ratio

0.25
MCK price to sales ratio is 0.25

PS ratio Sector rank

8.46%
MCK price to sales ratio is higher than 8.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$95.60B
MCK enterprise value is $95.60 billion

Enterprise value Sector rank

98.02%
MCK enterprise value is higher than 98.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

19.28
MCK EV/EBITDA is 19.28

EV/EBITDA Sector rank

91.22%
MCK EV/EBITDA is higher than 91.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.92
MCK annual current ratio is 0.92

Quick ratio

0.51
MCK annual quick ratio is 0.51

Leverage

Debt to equity

-2.86
MCK annual debt to equity ratio is -2.86

Interest coverage ratio

16.04
MCK annual interest coverage ratio is 16.04

Risk & Stability

Piotroski F-Score

6
MCK piotroski f-score is 6

Altman Z-Score

5.77
MCK altman z-score is 5.77

Analyst ratings

Recent major analysts updates

Apr 11, 25 B of A Securities
Buy
Apr 3, 25 Mizuho
Neutral
Apr 2, 25 Morgan Stanley
Overweight
Mar 14, 25 Wells Fargo
Equal-Weight
Feb 6, 25 Evercore ISI Group
Outperform
Jan 10, 25 Citigroup
Buy
Jan 6, 25 B of A Securities
Buy
Dec 17, 24 Morgan Stanley
Overweight
Dec 13, 24 Wells Fargo
Equal-Weight
Nov 13, 24 Citigroup
Buy

Institutional Ownership

Similar stocks

CVS logo
CVS Health (CVS)
HCA logo
HCA Healthcare (HCA)
CI logo
Cigna (CI)
ELV logo
Elevance Health (ELV)
GSK logo
GSK (GSK)
BMY logo
Bristol-Myers Squibb (BMY)
ZTS logo
Zoetis (ZTS)
MDT logo
Medtronic (MDT)
REGN logo
Regeneron Pharmaceuticals (REGN)
  • What is the ticker symbol for McKesson?
  • Does McKesson pay dividends?
  • What sector is McKesson in?
  • What industry is McKesson in?
  • What country is McKesson based in?
  • When did McKesson go public?
  • Is McKesson in the S&P 500?
  • Is McKesson in the NASDAQ 100?
  • Is McKesson in the Dow Jones?
  • When was McKesson's last earnings report?
  • When does McKesson report earnings?
  • Should I buy McKesson stock now?

What is the ticker symbol for McKesson?

The ticker symbol for McKesson is NYSE:MCK

Does McKesson pay dividends?

Yes, McKesson pays dividends. The last payment was $0.71, with an ex-dividend date on March 3, 2025

What sector is McKesson in?

McKesson is in the Healthcare sector

What industry is McKesson in?

McKesson is in the Medical Distribution industry

What country is McKesson based in?

McKesson is headquartered in United States

When did McKesson go public?

McKesson's initial public offering (IPO) was on November 10, 1994

Is McKesson in the S&P 500?

Yes, McKesson is included in the S&P 500 index

Is McKesson in the NASDAQ 100?

No, McKesson is not included in the NASDAQ 100 index

Is McKesson in the Dow Jones?

No, McKesson is not included in the Dow Jones index

When was McKesson's last earnings report?

McKesson's most recent earnings report was on Feb 5, 2025

When does McKesson report earnings?

The next expected earnings date for McKesson is May 7, 2025

Should I buy McKesson stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page